Rift Valley Fever Outbreak Investigation Associated with a Dairy Farm Abortion Storm, Mbarara District, Western Uganda, 2023
- PMID: 40733631
- PMCID: PMC12298680
- DOI: 10.3390/v17071015
Rift Valley Fever Outbreak Investigation Associated with a Dairy Farm Abortion Storm, Mbarara District, Western Uganda, 2023
Abstract
In Africa, Rift Valley Fever poses a substantial risk to animal health, and human cases occur after contact with infected animals or their tissues. RVF has re-emerged in Uganda after nearly five decades, with multiple outbreaks recorded since 2016. We investigated a unique RVF outbreak associated with an animal abortion storm of 30 events and human cases on a dairy farm in Mbarara District, Western Uganda, in February 2023. Genomic analysis was performed, comparing animal and human RVF viruses (RVFV) circulating in the region. A cluster of thirteen human RVF cases and nine PCR-positive animals could directly be linked with the abortion storm. Overall, during the year 2023, we confirmed 61 human RVFV cases across Uganda, 88.5% of which were reported to have had direct contact with livestock, and a high case fatality rate of 31%. We recommend implementing extensive health education programs in affected communities and using sustainable mosquito control strategies to limit transmission in livestock, coupled with initiating animal vaccination trials in Uganda.
Keywords: RVF virus; Rift Valley Fever; animal abortion storms; human RVF outbreak; livestock–human interface; vaccination trials; western Uganda; zoonotic transmission.
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of this study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures
References
-
- Shoemaker T.R., Nyakarahuka L., Balinandi S., Ojwang J., Tumusiime A., Mulei S., Kyondo J., Lubwama B., Sekamatte M., Namutebi A., et al. First Laboratory-Confirmed Outbreak of Human and Animal Rift Valley Fever Virus in Uganda in 48 Years. Am. J. Trop. Med. Hyg. 2019;100:659–671. doi: 10.4269/ajtmh.18-0732. - DOI - PMC - PubMed
-
- Nyakarahuka L., de St Maurice A., Purpura L., Ervin E., Balinandi S., Tumusiime A., Kyondo J., Mulei S., Tusiime P., Lutwama J., et al. Prevalence and Risk Factors of Rift Valley Fever in Humans and Animals from Kabale District in Southwestern Uganda, 2016. PLoS Negl. Trop. Dis. 2018;12:e0006412. doi: 10.1371/journal.pntd.0006412. - DOI - PMC - PubMed
-
- Nyakarahuka L., Whitmer S., Klena J., Balinandi S., Talundzic E., Tumusiime A., Kyondo J., Mulei S., Patel K., Baluku J., et al. Detection of Sporadic Outbreaks of Rift Valley Fever in Uganda through the National Viral Hemorrhagic Fever Surveillance System, 2017–2020. Am. J. Trop. Med. Hyg. 2023;1:995–1002. doi: 10.4269/ajtmh.22-0410. - DOI - PMC - PubMed
-
- Shoemaker T.R., Balinandi S., Tumusiime A., Nyakarahuka L., Lutwama J., Mbidde E., Kofman A., Klena J.D., Ströher U., Rollin P.E., et al. Impact of Enhanced Viral Haemorrhagic Fever Surveillance on Outbreak Detection and Response in Uganda. Lancet Infect. Dis. 2018;18:373–375. doi: 10.1016/S1473-3099(18)30164-6. - DOI - PMC - PubMed
Publication types
MeSH terms
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
